ArticleMikrochimica acta2026
Dual-pore size covalent organic frameworks shelled magnetic particles for anti-microbial peptide and microprotein enrichment with simultaneous exclusion of large proteins.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial peptides (AMPs) are critical effectors of innate immunity and promising alternatives to conventional antibiotics. However, their low abundance and interference from high-molecular-weight proteins in biological matrices hinder their selective enrichment and detection. Here, we report the design and synthesis of dual-pore covalent organic framework (COF)-shelled magnetic particles (M-Si@COF12) for efficient AMP and microprotein enrichment. The particles consist of magnetic core coated with silica (M-Si), followed by room-temperature, silanol-initiated growth of hair-like COF structures. This unique design provides precise control over hydrophobicity and dual pore sizes (2.7 and 3.2 nm), facilitating both size-selective and affinity-driven capture of low-molecular-weight bioactive peptides. M-Si@COF12 exhibits a high surface area (1014.95 m²/g), strong adsorption capacity (39.36 mg/g), and excellent selectivity toward AMPs. The material was validated using human serum and K-562 cell lysate, demonstrating effective enrichment of AMPs and AMP-like hydrophobic peptides (microprotein mimics). The particles are also reusable without significant loss of performance. This work presents a facile, scalable, and reusable material platform for targeted enrichment of bioactive microproteins, establishing a potential foundation for future applications in clinical proteomics and biomarker discovery.
Indexed as
Identifiers
41872528What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.